| Literature DB >> 28811513 |
Marie Brossard-Racine1,2, Jonathan Murnick3, Marine Bouyssi-Kobar4, Janie Coulombe5, Taeun Chang6, Catherine Limperopoulos7.
Abstract
This study aims to compare the cerebellar biochemical profiles in preterm (PT) infants evaluated at term equivalent age (TEA) and healthy full-term newborns using proton magnetic resonance spectroscopy (1H-MRS). We explore the associations between altered cerebellar metabolite profiles and brain injury topography, severity of injury, and prematurity-related clinical complications. We prospectively collected high quality 1H-MRS in 59 premature infants born ≤32 weeks and 61 healthy full term controls. 1H-MRS data were processed using LCModel software to calculate absolute metabolite concentration for N-acetyl-aspartate (NAA), choline (Cho) and creatine (Cr). PT infants had significantly lower cerebellar NAA (p < 0.025) and higher Cho (p < 0.001) at TEA when compared to healthy controls. Creatine was not different between the two groups. The presence of cerebellar injury was consistently associated with reduced concentrations for NAA, Cho, and Cr. Postnatal infection was negatively associated with NAA and Cr (p < 005), while cerebral cortical brain injury severity was inversely associated with both Cho and Cr (p < 0.01). We report for the first time that premature birth is associated with altered cerebellar metabolite profiles when compared to term born controls. Infection, cerebellar injury and supratentorial injury are important risk factors for impaired preterm cerebellar biochemistry.Entities:
Year: 2017 PMID: 28811513 PMCID: PMC5557848 DOI: 10.1038/s41598-017-08195-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Clinical characteristics of the cohort (N = 120).
| Term (n = 61) | Preterm (n = 59) | |
|---|---|---|
| Mean ± SD/Median[range] | Mean ± SD/Median[range] | |
|
| ||
| Clinical chorioamnionitis n (%) | 0 (0%) | 14 (23.7) |
| GA at birth (weeks)** | 39.6 ± 1.2 | 26.7 ± 2.7 |
| Birth weight (grams)** | 3321 ± 364 | 872 ± 334 |
| Female n (%) | 28 (45.9) | 33 (55.9) |
| Intubation at birth n (%) | 0 (0%) | 27 (48.2) |
| Apgar score 1 min**/5 min** | 8[6–9]/9[8–9] | 4 [1–9]/7[1–9] |
| Patent ductus arteriosus ligation n (%) | NA | 19 (32.2) |
| Surgery for necrotizing enterocolitis n (%) | NA | 29 (49.2) |
| Neonatal infection n (%) | NA | 21 (35.6) |
| Days on mechanical ventilation | NA | 30 ± 38 |
| Days on supplementary oxygen | NA | 86 ± 51 |
| Chronic lung disease n (%) | NA | 38 (64.4%) |
| Days in NICU | NA | 120 [30–205] |
|
| ||
| Gestational age at MRI (weeks)** | 41.5 [38.3–45.6] | 39.9 [35.3–44.4] |
| Day of life at MRI** | 12 [4–31] | 96 [30–138] |
| White matter injury score | NA | 3 [0–16] |
| Combined grey matter injury score | NA | 1 [0–9] |
| Cerebellar score | NA | 1 [0–7] |
Legend: **p < 0.01.
Absolute concentrations of brain metabolite in preterm and healthy full-term controls (Mean ± SD)1.
| Metabolites2 | Preterm | Control | P-values |
|---|---|---|---|
| tNAA | 6.817 ± 1.936 | 8.282 ± 1.755 | 0.025 |
| tCho | 6.012 ± 1.295 | 5.434 ± 0.737 | <0.001 |
| tCr | 9.608 ± 2.110 | 10.200 ± 1.721 | 0.693 |
Legend: 1controlling for GA at MRI; 2concentration is in mM/kg.
Best forward multiple linear regression models of clinical complications associated with cerebellar metabolites1.
| Metabolites | R2 (models’ p-values) | Variables | Standardized coefficients | Variables’ p-values |
|---|---|---|---|---|
| tNAA | 0.315 (<0.001) | GA | 0.474 | <0.001 |
| Infection | −0.247 | 0.042 | ||
| CBI | −0.298 | 0.012 | ||
| tCho | 0.356 (<0.001) | GA | 0.384 | 0.001 |
| CBI | −0.349 | 0.002 | ||
| Combined grey matter injury | −0.381 | 0.001 | ||
| tCr | 0.514 (<0.001) | GA | 0.641 | <0.001 |
| CBI | −0.706 | <0.001 | ||
| Infection | −1.075 | 0.015 | ||
| Combined grey matter injury | −0.273 | 0.017 |
Legend: 1in mM/kg; GA, gestational age at MRI; CBI, cerebellar injury.
Figure 1Example of a single 1H-MRS voxel placed in the middle of the cerebellum on corresponding sagittal, coronal and axial T2 images.
Figure 2Typical good quality LCmodel spectra output obtained in a preterm infant at 38.14 weeks of age.
Figure 3Typical good quality LCmodel spectra output obtained in a healthy control at 39.43 weeks of age.